Vivtex is set to receive research funding, upfront payments, milestone payments up to $2.1bn, and tiered royalties.

A new animal study raises important questions about a little-known ingredient used in oral weight-loss medications. A pill ...

The partnership pairs Novo Nordisk’s expertise in protein therapeutics with Vivtex’s gastrointestinal screening and formulation platform.

Partnership will leverage Vivtex’s proprietary technologies built to identify optimal oral formulations for peptide and ...

Novo Nordisk launched an oral formulation of its peptide-based GLP-1 agonist Wegovy (semaglutide) in the US a few weeks ago, claiming a lead in a category that until then was made up mainly by ...

New research shows that certain flavonols from everyday foods can shut down the body’s drug-resistance machinery, potentially paving the way for more effective treatments, but clinical hurdles remain.

Tonix Pharmaceuticals launched a campaign to highlight gastroparesis' impact on oral migraine medication absorption, promoting non-oral treatments. Gastroparesis, often comorbid with migraines, ...

In this interview, Karl Box shows how particle drift analysis with flux techniques enhances oral drug absorption in pharmaceutical research. Can you tell us about Pion’s Rainbow Dynamic Dissolution ...

In this video, Melissa Shoemaker, MD, MPH, compares oral GLP-1 medication to previous anti-obesity treatments.